EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control

Dongpeng Zheng, Fengqi Li iD, Zhuang Zhang, Yunyi Dong, Xuebin Zhang, Xueren Li, Jingyue Yang iD, Shouchun Peng, Budong Chen iD, Shupeng Sun iD, Zichuan Liu iD, Xin Mu iD

Proceedings of the National Academy of Sciences · 23.06.2026 · 123 (25)

DOI: 10.1073/pnas.2529973123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 18.06.2026. Verfasst von Dongpeng Zheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300072, China. Hauptthemen laut MEDLINE: Killer Cells, Natural, Glioblastoma, Glycoproteins, Brain Neoplasms. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune-mediated killing triggers dynamic transcriptional adaptations in tumor cells that can reciprocally regulate the cytolytic process. Unraveling such feedback mechanisms is crucial for advancing cancer immunotherapy. Here, we identified tissue factor pathway inhibitor 2 (TFPI2) as a central node in natural killer (NK)–glioblastoma cross talk. Using transcriptomic and functional approaches, we demonstrated that NK cell attack induces TFPI2 expression in glioblastoma cells via IL1β- and TNFα-driven activation of NFκB signaling. TFPI2 not only restrains tumor proliferation by suppressing the POU2F2–CCND1 axis but also enhances NK cytotoxicity through two complementary mechanisms: It supports optimal ICAM1 expression to promote NK–tumor adhesion, and it selectively represses the immune checkpoint molecule SIGLEC15, restoring NK cell effector function. In vivo, loss of TFPI2 accelerates glioblastoma progression and abrogates the efficacy of adoptive NK cell therapy in a context-dependent manner; the functionality is likely restricted to tumors retaining the capacity for TFPI2 induction upon inflammatory stimuli. Our findings identified the TFPI2–ICAM1 and TFPI2–SIGLEC15 axes as conditional regulators of immune–tumor adhesion and checkpoint control, supporting TFPI2 as a candidate therapeutic target for a subset of glioblastomas amenable to inflammatory reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalGlioblastomaGlycoproteinsBrain NeoplasmsHumansAnimalsCell AdhesionCell Line, TumorMiceIntercellular Adhesion Molecule-1Signal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ICAM1NKTFPI2glioblastoma

Substanzen

tissue-factor-pathway inhibitor 2GlycoproteinsIntercellular Adhesion Molecule-1

Autor:innen und Institutionen

  • School of Pharmaceutical Science and Technology, Faculty of Medicine, Tianjin University, Tianjin 300072, China.
  • State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin 300072, China.
  • The State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing 210042, China.
  • Tianjin University and Health-Biotech United Group Joint Laboratory of Innovative Drug Development and Translational Medicine, Tianjin University, Tianjin 300072, China.
  • Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin 300350, China.
  • Tianjin Key Laboratory of Cerebral Blood Flow Reconstruction and Head and Neck Tumor New Technology Translation, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institut…

ORCID-Profile: Fengqi Li, Jingyue Yang, Budong Chen, Shupeng Sun, Zichuan Liu, Xin Mu

Zitieren

APA

Zheng, D., Li, F., Zhang, Z., Dong, Y., Zhang, X., Li, X., Yang, J., Peng, S., Chen, B., Sun, S., Liu, Z., & Mu, X. (2026). TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control. Proceedings of the National Academy of Sciences, 123(25). https://doi.org/10.1073/pnas.2529973123

Vancouver

Zheng D, Li F, Zhang Z, Dong Y, Zhang X, Li X, et al. TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control. Proceedings of the National Academy of Sciences. 2026;123(25). doi:10.1073/pnas.2529973123

BibTeX
@article{Zheng2026,
  author = {Zheng, Dongpeng and Li, Fengqi and Zhang, Zhuang and Dong, Yunyi and Zhang, Xuebin and Li, Xueren and Yang, Jingyue and Peng, Shouchun and Chen, Budong and Sun, Shupeng and Liu, Zichuan and Mu, Xin},
  title = {TFPI2 promotes NK cell–mediated glioblastoma killing through adhesion and checkpoint control},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {25},
  doi = {10.1073/pnas.2529973123}
}
Kostenlos starten →